Facebook Twitter LinkedIn Google Plus RSS

Pharma and Life Sciences News

Valeant deal for North Carolina maker of gastrointestinal drugs valued at $14.5B

Valeant deal for North Carolina maker of gastrointestinal drugs valued at $14.5B

Drugmaker Valeant Pharmaceuticals International Inc. may have lost out in a bidding war for Allergan Inc. three months ago, but this weekend, it made...

Merck declares quarterly dividend

White House Station-based Merck announced Monday that its board of directors has declared a quarterly dividend for the second quarter of 2015.

15 lawyers leaving Sills Cummis & Gross for national firm's health care and life sciences practices

The national law firm Epstein Becker Green, based regionally in Newark, announced Monday that a group of 15 attorneys is leaving the Newark law firm...

Colliers: Agriculture-focused financial services firm relocating within Jersey City

A firm that provides financing to the agricultural industry is changing its address for the first time in 25 years, moving to 101 Hudson Street in...

Top N.J. business leaders heading to Cuba on trade mission trip with N.J. Tech Council

Top N.J. business leaders heading to Cuba on trade mission trip with N.J. Tech Council

At least a half-dozen top business leaders are scheduled to make a trip to Cuba in April to begin laying the groundwork to do business in Cuba...

Drugmaker's expansion could bring 300 new jobs to East Windsor

Aurobindo Pharma USA has purchased 90 acres in East Windsor Township to build a new distribution center, which could bring 300 new jobs to the state,...

Hampton-based biotherapy company prices IPO

Hampton-based Bellerophon Therapeutics announced Friday that it has priced its initial public offering.

New life sciences incubator opens on Kean campus

The Institute for Life Science Entrepreneurship announced the launch of its new life sciences incubator located in the state-of-the-art New Jersey...

Valeant CEO: We expect more than 20 percent growth

Valeant CEO: We expect more than 20 percent growth

On Nov. 13, Valeant Pharmaceuticals CEO J. Michael Pearson cut the ribbon on a new headquarters in Bridgewater, after getting nearly $39.5 million in...

NJBIZ Poll Question of the Week

Do you think your company will have use for a drone in the next five years? Vote View Results
close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!